Trial Profile
Risperidone augmentation therapy in patients who have failed or only partially responded to an adequate trial of antidepressant
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Depression; Depressive disorders
- Focus Therapeutic Use
- 23 Aug 2007 The expected completion date for this trial is now 1 Feb 2005.
- 30 Dec 2005 New trial record.